FDA Clears CDC Diagnostic For COVID-19 And Influenza
US Agency Also Encourages Combination Test Development With Template Updates
The US FDA has authorized marketing of a combination diagnostic that can detect either COVID-19 or influenza. The agency hopes to encourage development of additional similar tests before the fall flu season.
You may also be interested in...
Roche's diagnostics division grew 3% in the first half of 2020 with exploding demand for COVID-19 tests offsetting declines in routine testing.
It was a quiet month for warning letters at the FDA last month, with the agency issuing no new warning letters and closing out only one.
A proposed rule from the US Food and Drug Administration would allow the agency to take on regulation of lab-developed tests by phasing out the previous approach of enforcement discretion